Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea's Medison Becomes Samsung Electronics Affiliate With Samsung Executive Appointed CEO

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's leading medical equipment maker Medison Co. announced Feb. 16 that it became an affiliate of Samsung Electronics two months after the electronics giant bought a controlling stake in Medison and its local affiliate Prosonic for roughly KRW 300 billion ($262.8 million)

You may also be interested in...



Korea’s Antitrust Watchdog Bares Teeth At GE, Siemens, Philips For Medical Device Rebates

The government of President Park has widened its anti-rebate stance as the fair trade watchdog looks into medical device companies.

With Samsung's Push For MabThera Biosimilar, Roche Persists On Call For Strengthened Regulatory Framework

SEOUL - In reaction to South Korean firm Samsung Electronics' recent clinical trial application for its biosimilar of Roche's MabThera, Roche said that it supports developing a regulatory framework for biosimilars that would apply the same stringent standards as those applied to originator products to ensure the protection of public health

Samsung Electronics Takes Over Leading Medical Device Maker Medison

SEOUL - South Korea's Samsung Electronics is further building its burgeoning presence in the healthcare sector through the takeover of the country's leading medical equipment maker Medison Co. from a private equity fund

Related Content

UsernamePublicRestriction

Register

SC077188

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel